Xenon Pharmaceuticals Inc. (XENE) Ownership

$30.67

south_east
-$0.92 (-2.91%)
Day's range
$29.04
Day's range
$31.8

Xenon Pharmaceuticals Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 02/13/2025 7.53 M $294.99 M   8.78% 9.66%
AVORO CAPITAL ADVISORS LLC 02/14/2025 5.67 M $222.13 M   0.00% 7.27%
DRIEHAUS CAPITAL MANAGEMENT LLC 02/14/2025 4.52 M $177.21 M   -1.63% 5.80%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 3.78 M $148.08 M   -1.71% 4.85%
BRAIDWELL LP 02/14/2025 2.91 M $114.23 M   7.64% 3.74%
JANUS HENDERSON GROUP PLC 02/14/2025 2.87 M $112.43 M   12.32% 3.68%
COMMODORE CAPITAL LP 02/14/2025 2.74 M $107.41 M   1.48% 3.52%
POLAR CAPITAL HOLDINGS PLC 02/14/2025 2.70 M $105.75 M   10.35% 3.46%
CAPITAL INTERNATIONAL INVESTORS 02/13/2025 2.55 M $99.85 M   -1.32% 3.27%
CAPITAL WORLD INVESTORS 02/13/2025 2.29 M $89.95 M   -14.43% 2.94%
BLACKROCK, INC. 02/07/2025 2.11 M $82.53 M   -0.02% 2.70%
ADAGE CAPITAL PARTNERS GP, L.L.C. 02/14/2025 1.86 M $73.05 M   -10.58% 2.39%
PICTET ASSET MANAGEMENT HOLDING SA 02/12/2025 1.50 M $58.66 M   -2.11% 1.92%
ALLIANCEBERNSTEIN L.P. 02/12/2025 1.44 M $56.57 M   1.29% 1.85%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 02/14/2025 1.44 M $56.36 M   -4.39% 1.85%
JPMORGAN CHASE & CO 02/12/2025 1.36 M $53.19 M   38.91% 1.74%
ROCK SPRINGS CAPITAL MANAGEMENT LP 02/14/2025 1.25 M $49.07 M   -4.91% 1.61%
AFFINITY ASSET ADVISORS, LLC 02/13/2025 1.16 M $45.52 M   1.50% 1.49%
FIRST LIGHT ASSET MANAGEMENT, LLC 02/14/2025 1.16 M $45.49 M   -1.78% 1.49%
WESTFIELD CAPITAL MANAGEMENT CO LP 02/11/2025 1.16 M $45.36 M   72.82% 1.49%
SAMLYN CAPITAL, LLC 02/14/2025 1.02 M $39.90 M   -0.23% 1.31%
BAKER BROS. ADVISORS LP 02/14/2025 993,679 $38.95 M   0.00% 1.28%
ORBIMED ADVISORS LLC 02/14/2025 947,877 $37.16 M   4.00% 1.22%
MARSHALL WACE, LLP 02/13/2025 899,718 $35.27 M   -24.74% 1.15%
TIMESSQUARE CAPITAL MANAGEMENT, LLC 02/03/2025 848,850 $33.27 M   9.07% 1.09%
VESTAL POINT CAPITAL, LP 02/14/2025 810,000 $31.75 M   -1.82% 1.04%
JENNISON ASSOCIATES LLC 01/24/2025 801,553 $31.42 M   39.00% 1.03%
SIREN, L.L.C. 02/14/2025 743,769 $29.16 M   0.00% 0.95%
LOOMIS SAYLES & CO L P 02/12/2025 687,145 $26.94 M   -2.84% 0.88%
FIRST TURN MANAGEMENT, LLC 02/14/2025 684,986 $26.85 M   110.62% 0.88%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 02/12/2025 663,704 $26.02 M   51.16% 0.85%
02/14/2025 600,000 $23.52 M   100.00% 0.77%
FRANKLIN RESOURCES INC 02/12/2025 575,590 $22.56 M   1.71% 0.74%
FEDERATED HERMES, INC. 02/13/2025 558,500 $21.89 M   -24.14% 0.72%
FIERA CAPITAL CORP 01/29/2025 535,887 $21.01 M   -3.30% 0.69%
CANDRIAM S.C.A. 02/07/2025 492,181 $19.29 M   6.11% 0.63%
AVIDITY PARTNERS MANAGEMENT LP 02/14/2025 474,000 $18.58 M   -42.05% 0.61%
GOLDMAN SACHS GROUP INC 02/11/2025 410,246 $16.08 M   -10.74% 0.53%
STEMPOINT CAPITAL LP 02/14/2025 375,845 $14.73 M   100.00% 0.48%
MILLENNIUM MANAGEMENT LLC 02/14/2025 346,040 $13.56 M   65.55% 0.44%
VANGUARD GROUP INC 02/11/2025 342,779 $13.44 M   -0.46% 0.44%
CITADEL ADVISORS LLC 02/14/2025 327,303 $12.83 M   -54.70% 0.42%
PERCEPTIVE ADVISORS LLC 02/14/2025 325,324 $12.75 M   -38.03% 0.42%
SATURN V CAPITAL MANAGEMENT LLC 02/14/2025 322,470 $12.64 M   100.00% 0.41%
TWO SIGMA ADVISERS, LP 02/14/2025 298,700 $11.71 M   9.13% 0.38%
ALYESKA INVESTMENT GROUP, L.P. 02/14/2025 288,843 $11.32 M   0.00% 0.37%
STATE STREET CORP 02/14/2025 288,722 $11.32 M   3.29% 0.37%
ALTIUM CAPITAL MANAGEMENT LP 02/13/2025 288,000 $11.29 M   -20.13% 0.37%
ABRDN PLC 01/24/2025 283,899 $11.13 M   14.33% 0.36%
DAFNA CAPITAL MANAGEMENT LLC 02/14/2025 273,739 $10.73 M   0.00% 0.35%

Xenon Pharmaceuticals Inc. institutional Ownership - FAQ's

During the previous two years, 240 institutional investors and hedge funds held shares of Xenon Pharmaceuticals Inc.. The most heavily invested institutionals were:

FMR LLC: 7.53 M

Avoro Capital Advisors LLC: 5.67 M

DRIEHAUS CAPITAL MANAGEMENT LLC: 4.52 M

WELLINGTON MANAGEMENT GROUP LLP: 3.78 M

BRAIDWELL LP: 2.91 M

JANUS HENDERSON GROUP PLC: 2.87 M

97.90% of Xenon Pharmaceuticals Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 81.25 M shares in the last 24 months. This purchase volume represents approximately $2.49 B in transactions.